Spirituality, patients' worry, and follow-up health-care utilization among cancer survivors
| EVALUABLE (N) | LOW SPIRITUALITY | HIGH SPIRITUALITY | P | |||
|---|---|---|---|---|---|---|
| FREQUENCY | PERCENT | FREQUENCY | PERCENT | |||
| n | 551 | 271 | 49 | 280 | 51 | |
| Median age (range) | 59 (19–85) | 59 (22–83) | 0.99 | |||
| ≤40 | 551 | 17 | 6 | 21 | 8 | 0.78 |
| 41–60 | 137 | 51 | 135 | 48 | ||
| >60 | 117 | 43 | 124 | 44 | ||
| Sex | ||||||
| Female | 551 | 112 | 41 | 89 | 32 | 0.02 |
| Male | 159 | 59 | 191 | 68 | ||
| Race/ethnicity | ||||||
| White | 551 | 256 | 94 | 272 | 97 | 0.21 |
| Hispanic | 6 | 2 | 2 | 1 | ||
| African American | 3 | 1 | 4 | 1 | ||
| Other | 6 | 2 | 2 | 1 | ||
| Marital status | ||||||
| Single/never married | 551 | 14 | 5 | 19 | 7 | 0.67 |
| Married | 219 | 81 | 219 | 78 | ||
| Divorced/widowed | 38 | 14 | 42 | 15 | ||
| Education | ||||||
| High school | 551 | 90 | 33 | 83 | 30 | 0.49 |
| College | 105 | 39 | 122 | 44 | ||
| Postgraduate | 76 | 28 | 75 | 27 | ||
| Religion | ||||||
| Protestant | 551 | 121 | 45 | 161 | 58 | <0.01 |
| Catholic | 101 | 37 | 80 | 29 | ||
| Other | 36 | 13 | 35 | 13 | ||
| None/atheist | 13 | 5 | 4 | 1 | ||
| Income (US$) | ||||||
| <25,000 | 551 | 37 | 14 | 37 | 13 | 0.71 |
| 25,000–49,999 | 64 | 24 | 61 | 22 | ||
| 50,000–74,999 | 59 | 22 | 54 | 19 | ||
| 75,000–100,000 | 35 | 13 | 44 | 16 | ||
| >100,000 | 57 | 21 | 56 | 20 | ||
| Missing | 19 | 7 | 28 | 10 | ||
| Place of residence | ||||||
| Urban | 551 | 194 | 72 | 201 | 72 | 0.96 |
| Rural | 77 | 28 | 79 | 28 | ||
| Distance (miles) | ||||||
| ≤15 | 551 | 108 | 40 | 98 | 35 | 0.32 |
| 15–100 | 83 | 31 | 94 | 34 | ||
| 100–250 | 44 | 16 | 58 | 21 | ||
| >250 | 36 | 13 | 30 | 11 | ||
| Employment status | ||||||
| Full time | 551 | 160 | 59 | 163 | 58 | 0.93 |
| Part time | 22 | 8 | 27 | 10 | ||
| Homemaker | 25 | 9 | 26 | 9 | ||
| Student | 3 | 1 | 4 | 1 | ||
| Retired | 48 | 18 | 51 | 18 | ||
| Other | 13 | 5 | 9 | 3 | ||
| Patient is the primary income provider | 551 | 137 | 51 | 132 | 47 | 0.42 |
| Insurance | ||||||
| Employer-based | 551 | 149 | 55 | 153 | 55 | 0.95 |
| Individual-based | 47 | 17 | 48 | 17 | ||
| Medicare/Medicaid | 56 | 21 | 59 | 21 | ||
| Other | 17 | 6 | 16 | 6 | ||
| None | 2 | 1 | 4 | 1 | ||
| Prescription insurance | 551 | 239 | 88 | 242 | 86 | 0.53 |
| Type of malignancy | ||||||
| Leukemia, lymphoma, multiple myeloma | 551 | 136 | 50 | 147 | 53 | 0.86 |
| Breast, colon, prostate | 101 | 37 | 100 | 36 | ||
| Lung, pancreatic | 34 | 13 | 33 | 12 | ||
| Median time from diagnosis to study enrollment in years (range) | 4.5 (0.5–26.6) | 4.2 (0.6–26.6) | 0.28 | |||
| 0–2 years | 551 | 56 | 21 | 62 | 22 | 0.09 |
| 2–4 years | 70 | 26 | 76 | 27 | ||
| 4–8 years | 74 | 27 | 93 | 33 | ||
| >8 years | 71 | 26 | 49 | 18 | ||
| Median time from last treatment to study enrollment in years (range) | 3.6 (0.1–13.6) | 3.6 (0.4–18.7) | 0.87 | |||
| 0–2 years | 551 | 97 | 36 | 99 | 35 | 0.84 |
| 2–5 years | 83 | 31 | 92 | 33 | ||
| >5 years | 91 | 34 | 89 | 32 | ||
| Affiliation of follow-up provider | ||||||
| University-based | 551 | 193 | 71 | 190 | 68 | 0.16 |
| Community-based | 28 | 10 | 31 | 11 | ||
| Both | 50 | 18 | 54 | 19 | ||
| Missing | 0 | 0 | 5 | 2 | ||
| Treatment received | ||||||
| Chemotherapy only | 551 | 82 | 30 | 89 | 32 | 0.93 |
| Chemo + surgery + radiation | 125 | 46 | 126 | 45 | ||
| Stem cell transplantation | 64 | 24 | 65 | 23 | ||
| Prior treatment outside university | 551 | 116 | 43 | 126 | 45 | 0.60 |
Statistical Analysis
Participant characteristics were compared according to level of spirituality using a chi-square test for categorical data and the Wilcoxon test for continuous data (Table 1). Multivariate logistic regression models were fitted to evaluate separately the relationship between (1) spirituality with patient-rated worry as the outcome, (2) spirituality with follow-up health-care utilization as the outcome, and (3) patient-rated worry with follow-up health-care utilization as the outcome. In the above models, the following covariates were forced into each model: age, sex, cancer type, time from last cancer-related treatment to study start time, income, and type of medical insurance. These models were also fitted using outcomes ascertained at both 6 and 12 months. Interaction models between patient-rated worry and level of spirituality were also evaluated for an association with follow-up health-care utilization at 12 months to explore the role of spirituality in the relationship between patient-rated worry and health-care utilization. A P value of at least 0.05 was considered statistically significant.
Results
Study Participation
Of the 2,000 participants invited, 1,881 were deemed eligible (minus those who died or had wrong addresses). Baseline questionnaires were returned by 939 participants (baseline response rate of 50%). Seventeen wanted to participate only in the baseline survey. Of the 922 baseline participants, 691 returned the 6-month survey at the time of the analysis for this study, for a response rate of 76% when adjusted for deaths (182 no response, 18 deaths, 25 declined, 12 returned with wrong address). At 1 year, 691 surveys were mailed, with 588 surveys returned (58 no response, 17 deaths, 14 declined, 13 returned with wrong address, and one in hospice); a response rate of 87% was achieved after adjusting for deaths. Thirty-seven participants had missing information on spirituality, leaving a total of 551 included in this study. No differences in age, sex, and type of cancer were noted between patients included and excluded in the current analysis.
Characteristics of Study Participants
Demographic characteristics of the 551 study participants included in this study are shown in Table 1. We found that cancer survivors with low or high spirituality were more similar than different in all but two characteristics: highly spiritual survivors were more likely to be Protestant and male.
Prevalence of Spirituality and Patient Worry
Within our population, 271 (49%) survivors reported low spirituality and 280 (51%) reported high spirituality (Table 1). Also, at baseline, 277 (51%) survivors reported high levels of recurrence/progression-related worry, 190 survivors (35%) reported high levels of new malignancy–related worry, and 178 survivors (33%) reported high levels of treatment-related complication worry. As some participants may have reported one or more types of worry, this translates to 322 (59%) reporting any type of worry. Highly spiritual survivors reported significantly lower levels of high worry concerning recurrence/progression (6-month 27% vs. 38%, P < 0.01; 12-month 21% vs. 38%, P < 0.01), development of a different type of cancer (6-month 22% vs. 31%, P = 0.03; 12-month 15% vs. 26%, P < 0.01), and complications from treatment (6-month 17% vs. 30%, P < 0.01; 12-month 16% vs. 26%, P < 0.01). Highly spiritual survivors reported significantly lower levels for any type of worry at both 6 and 12 months (6 months 37% vs. 54%, P <0.01; 12 months 28% vs. 47%, P < 0.01) (Table 2).
| BASELINE | 6-MONTH | 12-MONTH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| LOW SPIRITUALITY, N (%) | HIGH SPIRITUALITY, N (%) | P | LOW SPIRITUALITY, N (%) | HIGH SPIRITUALITY, N (%) | P | LOW SPIRITUALITY, N (%) | HIGH SPIRITUALITY, N (%) | P | ||
| Recurrence/progression-related worry | Low | 106 (40) | 160 (58) | <0.01 | 154 (62) | 184 (73) | <0.01 | 166 (62) | 218 (79) | <0.01 |
| High | 160 (60) | 117 (42) | 95 (38) | 69 (27) | 103 (38) | 59 (21) | ||||
| New primary–related worry | Low | 158 (59) | 200 (72) | <0.01 | 172 (69) | 202 (78) | 0.03 | 199 (74) | 235 (85) | <0.01 |
| High | 111 (41) | 79 (28) | 76 (31) | 58 (22) | 71 (26) | 42 (15) | ||||
| Complication-related worry | Low | 166 (61) | 203 (73) | <0.01 | 175 (70) | 214 (83) | <0.01 | 200 (74) | 232 (84) | <0.01 |
| High | 104 (39) | 74 (27) | 74 (30) | 45 (17) | 69 (26) | 44 (16) | ||||
| Any worry | Low | 85 (32) | 138 (50) | <0.01 | 120 (46) | 165 (63) | <0.01 | 142 (53) | 198 (72) | <0.01 |
| High | 182 (68) | 140 (50) | 139 (54) | 97 (37) | 128 (47) | 78 (28) | ||||